Unique features of memory T cells in HIV elite controllers: A systems biology perspective

Current Opinion in HIV and AIDS

Volumn 6, Issue 3, 2011, Pages 188-196

  Fonseca, Simone G ^a   Procopio, Francesco A ^a   Goulet, Jean Philippe ^b,c   Yassine Diab, Bader ^b,c   Ancuta, Petronela ^b,c   Sékaly, Rafick Pierre ^a,b,c  

^a Vaccine and Gene Therapy Institute Florida (VGTI FL)   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

elite controllers; HIV; memory T cells; nonprogression; survival; systems biology

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 7; INTERLEUKIN 9; STAT5 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FKHRL1; TRANSFORMING GROWTH FACTOR BETA;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL SURVIVAL; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE SUBPOPULATION; VIRUS TRANSMISSION;

ANIMALS; CD4 LYMPHOCYTE COUNT; GENE EXPRESSION PROFILING; HIV; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HUMANS; IMMUNOLOGIC MEMORY; PRIMATES; SIGNAL TRANSDUCTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SYSTEMS BIOLOGY; T-LYMPHOCYTES; VIREMIA;

EID: 79955463873     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e32834589a1     Document Type: Review

References (93)

1. Lefrere JJ, Morand-Joubert L, Mariotti M, et al. Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection. Blood 1997; 90:1133-1140. (Pubitemid 27314149)
2. Migueles SA, Connors M. Long-term nonprogressive disease among untreated HIV-infected individuals: Clinical implications of understanding immune control of HIV. J Am Med Assoc 2010; 304:194-201.
3. Deeks SG, Walker BD. Human immunodeficiency virus controllers: Mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007; 27:406-416. (Pubitemid 47418678)
4. Pereyra F, Jia X, McLaren PJ, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010; 330:1551-1557.
5. Averdam A, Petersen B, Rosner C, et al. A novel system of polymorphic and diverse NK cell receptors in primates. PLoS Genet 2009; 5:e1000688..
6. Levy JA, Hsueh F, Blackbourn DJ, et al. CD8 cell noncytotoxic antiviral activity in human immunodeficiency virus-infected and -uninfected children. J Infect Dis 1998; 177:470-472. (Pubitemid 28063778)
7. van Grevenynghe J, Procopio FA, He Z, et al. Transcription factor FOXO3a controls the persistence of memory CD4+ T cells during HIV infection. Nat Med 2008; 14:266-274. (Pubitemid 351347916)
8. Gale RP, Feig SA, Sarna G. A cytoreductive conditioning program for bone marrow transplantation in resistant leukemia (SCARI). Transplant Proc 1977; 9:177-180.
9. Gaucher D, Therrien R, Kettaf N, et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 2008; 205:3119-3131.
10. Querec TD, Akondy RS, Lee EK, et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009; 10:116-125.
11. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: Implications for vaccine development. Nat Rev Immunol 2002; 2:251-262. (Pubitemid 37323225)
12. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: Function, generation, and maintenance. Annu Rev Immunol 2004; 22:745-763. (Pubitemid 38680440)
13. Zanetti M, Franchini G. T cell memory and protective immunity by vaccination: Is more better? Trends Immunol 2006; 27:511-517. (Pubitemid 44499159)
14. O'Connell KA, Bailey JR, Blankson JN. Elucidating the elite: mechanisms of control in HIV-1 infection. Trends Pharmacol Sci 2009; 30:631-637.
15. Sallusto F, Lenig D, Forster R, et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-712.
16. Hazenberg MD, Otto SA, Hamann D, et al. Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation. AIDS 2003; 17:1419-1424. (Pubitemid 36900541)
17. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291:2413-2417. (Pubitemid 32231804)
18. Willinger T, Freeman T, Hasegawa H, et al. Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets. J Immunol 2005; 175:5895-5903. (Pubitemid 41508074)
19. Wherry EJ, Teichgraber V, Becker TC, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003; 4:225-234. (Pubitemid 36322131)
20. Bouneaud C, Garcia Z, Kourilsky P, Pannetier C. Lineage relationships, homeostasis, and recall capacities of central- and effector-memory CD8 T cells in vivo. J Exp Med 2005; 201:579-590. (Pubitemid 40289548)
21. Wu CY, Kirman JR, Rotte MJ, et al. Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo. Nat Immunol 2002; 3:852-858.
22. Riou C, Yassine-Diab B, Van grevenynghe J, et al. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells. J Exp Med 2007; 204:79-91. (Pubitemid 46148759)
23. Bostik P, Noble ES, Stephenson ST, et al. CD4+ T cells from simian immunodeficiency virus disease-resistant sooty mangabeys produce more IL-2 than cells from disease-susceptible species: Involvement of p300 and CREB at the proximal IL-2 promoter in IL-2 up-regulation. J Immunol 2007; 178:7720-7729. (Pubitemid 46898043)
24. Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997; 278:1447-1450. (Pubitemid 27509814)
25. Potter SJ, Lacabaratz C, Lambotte O, et al. Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: An ANRS EP36 study. J Virol 2007; 81:13904-13915. (Pubitemid 350247883)
26. Emu B, Sinclair E, Favre D, et al. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol 2005; 79:14169-14178. (Pubitemid 41552715)
27. Tilton JC, Luskin MR, Johnson AJ, et al. Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load. J Virol 2007; 81:2713-2725. (Pubitemid 46447036)
28. Younes SA, Yassine-Diab B, Dumont AR, et al. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J Exp Med 2003; 198:1909-1922. (Pubitemid 38032123)
29. Kalams SA, Walker BD. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med 1998; 188:2199-2204. (Pubitemid 29028492)
30. Rotger M, Dang KK, Fellay J, et al.Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLoS Pathog 2010; 6:e1000781.
31. Loke P, Favre D, Hunt PW, et al. Correlating cellular and molecular signatures of mucosal immunity that distinguish HIV controllers from noncontrollers. Blood 2010; 115:e20-e32.
32. Vigneault F, Woods M, Buzon M, et al. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers. J Virol 2010 [PubMed: 21177805].
33. Saez-Cirion A, Lacabaratz C, Lambotte O, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci U S A 2007; 104:6776-6781. (Pubitemid 47175577)
34. Saez-Cirion A, Sinet M, Shin SY, et al. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: Association with Gag-specific CD8 T cell responses. J Immunol 2009; 182:7828-7837.
35. Cocchi F, Devico AL, Garzino-Demo A, et al. Response: Role of betachemokines in suppressing HIV replication. Science 1996; 274:1394-1395.
36. Cocchi F, DeVico AL, Garzino-Demo A, et al. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat Med 1996; 2:1244-1247. (Pubitemid 26375410)
37. Levy JA, Mackewicz CE, Barker E. Controlling HIV pathogenesis: The role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today 1996; 17:217-224. (Pubitemid 26148565)
38. Levy JA. The search for the CD8+ cell anti-HIV factor (CAF). Trends Immunol 2003; 24:628-632. (Pubitemid 37485911)
39. Hersperger AR, Pereyra F, Nason M, et al. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog 2010; 6:e1000917.
40. Ferre AL, Hunt PW, Critchfield JW, et al. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood 2009; 113:3978-3989.
41. Allard EL, Hardy MP, Leignadier J, et al. Overexpression of IL-21 promotes massive CD8+ memory T cell accumulation. Eur J Immunol 2007; 37:3069-3077. (Pubitemid 350138977)
42. Williams LD, Bansal A, Sabbaj S, et al. Interleukin-21-producing HIV-1- specific CD8 T cells are preferentially seen in elite controllers. J Virol 2010 [PubMed: 21159862].
43. Chevalier MF, Julg B, Pyo A, et al. HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIVspecific CD8+ T cell function. J Virol 2011; 85:733-741.
44. Nosaka T, Kawashima T, Misawa K, et al. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J 1999; 18:4754-4765. (Pubitemid 29415529)
45. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006; 127:469-480.
46. Bluestone JA, Hebrok M. Safer, longer-lasting regulatory T cells with betacatenin. Nat Med 2008; 14:118-119. (Pubitemid 351214545)
47. Dehner M, Hadjihannas M, Weiske J, et al. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serumand glucocorticoid-inducible kinase 1. J Biol Chem 2008; 283:19201-19210.
48. Kandasamy K, Mohan SS, Raju R, et al. NetPath: a public resource of curated signal transduction pathways. Genome Biol 2010; 11:R3.
49. Chan AC, Iwashima M, TurckCW, Weiss A. ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell 1992; 71:649-662.
50. Bubeck Wardenburg J, Fu C, Jackman JK, et al. Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function. J Biol Chem 1996; 271:19641-19644. (Pubitemid 26281693)
51. Zhang W, Trible RP, Samelson LE. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity 1998; 9:239-246. (Pubitemid 28400037)
52. Jordan MS, Sadler J, Austin JE, et al. Functional hierarchy of the N-terminal tyrosines of SLP-76. J Immunol 2006; 176:2430-2438. (Pubitemid 43201693)
53. Trautmann L, Janbazian L, Chomont N, et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006; 12:1198-1202. (Pubitemid 44527357)
54. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443:350-354. (Pubitemid 44435155)
55. Petrovas C, Casazza JP, Brenchley JM, et al. PD-1 is a regulator of virusspecific CD8+ T cell survival in HIV infection. J Exp Med 2006; 203:2281-2292. (Pubitemid 44498363)
56. Tan JT, Ernst B, Kieper WC, et al. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med 2002; 195:1523-1532. (Pubitemid 34666066)
57. Khaled AR, Durum SK. Lymphocide: Cytokines and the control of lymphoid homeostasis. Nat Rev Immunol 2002; 2:817-830. (Pubitemid 37328705)
58. Migliaccio M, Alves PM, Romero P, Rufer N. Distinct mechanisms control human naive and antigen-experienced CD8+ T lymphocyte proliferation. J Immunol 2006; 176:2173-2182. (Pubitemid 43201664)
59. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000; 1:426-432.
60. Schluns KS, Williams K, Ma A, et al. Cutting edge: Requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol 2002; 168:4827-4831. (Pubitemid 34495942)
61. Mueller YM, Petrovas C, Bojczuk PM, et al. Interleukin-15 increases effector memory CD8+ T cells and NK Cells in simian immunodeficiency virusinfected macaques. J Virol 2005; 79:4877-4885. (Pubitemid 40464238)
62. Purton JF, Tan JT, Rubinstein MP, et al. Antiviral CD4+ memory T cells are IL-15 dependent. J Exp Med 2007; 204:951-961. (Pubitemid 46631622)
63. Kondrack RM, Harbertson J, Tan JT, et al. Interleukin 7 regulates the survival and generation of memory CD4 cells. J Exp Med 2003; 198:1797-1806. (Pubitemid 38032113)
64. Seddon B, Tomlinson P, Zamoyska R. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol 2003; 4:680-686. (Pubitemid 36874445)
65. Akashi K, Kondo M, von Freeden-Jeffry U, et al. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 1997; 89:1033-1041. (Pubitemid 127678737)
66. Kieper WC, Tan JT, Bondi-Boyd B, et al. Overexpression of interleukin (IL)-7 leads to IL-15-independent generation of memory phenotype CD8+ T cells. J Exp Med 2002; 195:1533-1539. (Pubitemid 34666067)
67. Blattman JN, Grayson JM, Wherry EJ, et al. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med 2003; 9:540-547. (Pubitemid 36597099)
68. Bai F, Bellistri GM, Tincati C, et al. Reduced CD127 expression on peripheral CD4+ T cells impairs immunological recovery in course of suppressive highly active antiretroviral therapy. AIDS 2010; 24:2590-2593.
69. Vranjkovic A, Crawley AM, Patey A, Angel JB. IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection. J Leukoc Biol 2010 [PubMed: 21177484].
70. Danielpour D, Song K. Cross-talk between IGF-I and TGF-beta signaling pathways. Cytokine Growth Factor Rev 2006; 17:59-74. (Pubitemid 43117516)
71. Chabanon A, Desterke C, Rodenburger E, et al. A cross-talk between stromal cell-derived factor-1 and transforming growth factor-beta controls the quiescence/ cycling switch of CD34+ progenitors through FoxO3 and mammalian target of rapamycin. Stem Cells 2008; 26:3150-3161.
72. Estes JD, Harris LD, Klatt NR, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 2010; 6.
73. Cassol E, Malfeld S, Mahasha P, et al. Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy. J Infect Dis 2010; 202:723-733.
74. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371. (Pubitemid 44924494)
75. Hunt PW, Brenchley J, Sinclair E, et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 2008; 197:126-133. (Pubitemid 351263476)
76. Sankaran S, Guadalupe M, Reay E, et al. Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1- infected nonprogressors. Proc Natl Acad Sci U S A 2005; 102:9860-9865. (Pubitemid 40993658)
77. Favre D, Lederer S, Kanwar B, et al. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog 2009; 5:e1000295.
78. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004; 16:3-9. (Pubitemid 38147427)
79. Funderburg N, Luciano AA, Jiang W, et al. Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS One 2008; 3:e1915.
80. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 2007; 8:239-245. (Pubitemid 46745373)
81. Kaur S, Sassano A, Dolniak B, et al. Role of the Akt pathway in mRNA translation of interferon-stimulated genes. Proc Natl Acad Sci U S A 2008; 105:4808-4813. (Pubitemid 351753828)
82. Su L, David M. Inhibition of B cell receptor-mediated apoptosis by IFN. J Immunol 1999; 162:6317-6321. (Pubitemid 29309349)
83. Cui M, Huang Y, Zhao Y, Zheng J. Transcription factor FOXO3a mediates apoptosis in HIV-1-infected macrophages. J Immunol 2008; 180:898-906.
84. Noursadeghi M, Tsang J, Miller RF, Katz DR. Comment on 'Transcription factor FOXO3a mediates apoptosis in HIV-1-infected macrophages'. J Immunol 2008; 180:7783; author reply 7783-7784.
85. Sodora DL, Allan JS, Apetrei C, et al. Toward an AIDS vaccine: Lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 2009; 15:861-865.
86. Bosinger SE, Li Q, Gordon SN, et al. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 2009; 119:3556-3572.
87. Jacquelin B, Mayau V, Targat B, et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 2009; 119:3544-3555.
88. Harris LD, Tabb B, Sodora DL, et al. Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques. J Virol 2010; 84:7886-7891.
89. Mattapallil JJ, Douek DC, Hill B, et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005; 434:1093-1097. (Pubitemid 40663481)
90. Raffatellu M, Santos RL, Verhoeven DE, et al. Simian immunodeficiency virusinduced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008; 14:421-428. (Pubitemid 351499394)
91. Aujla SJ, Chan YR, Zheng M, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008; 14:275-281. (Pubitemid 351347908)
92. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28:454-467. (Pubitemid 351471762)
93. Brenchley JM, Paiardini M, Knox KS, et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008; 112:2826-2835.